Presented by Dr. Jincai Li, Vice President of WuXi Biologics Dr. Jincai (Jimmy) Li is currently Vice President of WuXi Biologics.  Dr. Li has over 17 years’ experience in Biologics process development, scale-up and cGMP manufacturing.  His group contributed to over 40 IND submissions, both in and outside of China, as well as BLA submission works.   Dr. Li joined WuXi Biologics in 2011, helped built and led the Cell Culture Process Development & pilot plant production group, and then managed the cGMP Drug Substance manufacturing facility. Before joining WuXi Biologics, Dr. Li was a cell culture process development Group Leader at Genentech Inc.  Before that, Dr. Li also worked at Tanox, Inc, where he led the manufacturing sciences group supporting PhIII production of a mAb product, and at Diversa Corporation (now BASF), in charge of process development for multiple recombinant enzyme projects. Dr. Li holds B.S. degree from Tsinghua University, and Ph.D. degree from University of Maryland Baltimore County, majoring in Chemical and Biochemical Engineering.

Hora

09:00 - 10:00 hs GMT+1

Organizador

BioPharma Asia Magazine
Compartir
Enviar a un amigo
Mi email *
Email destinatario *
Comentario *
Repite estos números *
Control de seguridad
Junio / 2020 923 webinars
Lunes
Martes
Miércoles
Jueves
Viernes
Sábado
Domingo
Lun 01 de Junio de 2020
Mar 02 de Junio de 2020
Mié 03 de Junio de 2020
Jue 04 de Junio de 2020
Vie 05 de Junio de 2020
Sáb 06 de Junio de 2020
Dom 07 de Junio de 2020
Lun 08 de Junio de 2020
Mar 09 de Junio de 2020
Mié 10 de Junio de 2020
Jue 11 de Junio de 2020
Vie 12 de Junio de 2020
Sáb 13 de Junio de 2020
Dom 14 de Junio de 2020
Lun 15 de Junio de 2020
Mar 16 de Junio de 2020